AAAAAA
Results: 1-25/33
Authors:
Zoulim, F
Citation: F. Zoulim, Detection of hepatitis B virus resistance to antivirals, J CLIN VIRO, 21(3), 2001, pp. 243-253
Authors:
Querenghi, F
Yu, Q
Billaud, G
Maertens, G
Trepo, C
Zoulim, F
Citation: F. Querenghi et al., Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy, J VIRAL HEP, 8(2), 2001, pp. 120-131
Authors:
Merle, P
Trepo, C
Zoulim, F
Citation: P. Merle et al., Current management strategies for hepatitis B in the elderly, DRUG AGING, 18(10), 2001, pp. 725-735
Authors:
Zoulim, F
Werle, B
Citation: F. Zoulim et B. Werle, Current knowledge on chronic hepatitis B therapy, GASTRO CL B, 25(4), 2001, pp. B143-B151
Authors:
Serfaty, L
Thabut, D
Zoulim, F
Andreani, T
Chazouilleres, O
Carbonell, N
Loria, A
Poupon, R
Citation: L. Serfaty et al., Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: Results ofa pilot study, HEPATOLOGY, 34(3), 2001, pp. 573-577
Authors:
Borel, C
Schorr, O
Durand, I
Zoulim, F
Kay, A
Trepo, C
Hantz, O
Citation: C. Borel et al., Initial amplification of duck hepatitis B virus covalently closed circularDNA after in vitro infection of embryonic duck hepatocytes is increased bycell cycle progression, HEPATOLOGY, 34(1), 2001, pp. 168-179
Authors:
Wartelle-Bladou, C
Lafon, J
Trepo, C
Pichoud, C
Picon, M
Pellissier, JF
Zoulim, F
Citation: C. Wartelle-bladou et al., Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection, J HEPATOL, 34(5), 2001, pp. 774-779
Authors:
Chemin, I
Zoulim, F
Merle, P
Arkhis, A
Chevallier, M
Kay, A
Cova, L
Chevallier, P
Mandrand, B
Trepo, C
Citation: I. Chemin et al., High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology, J HEPATOL, 34(3), 2001, pp. 447-454
Authors:
Seigneres, B
Aguesse-Germon, S
Pichoud, C
Vuillermoz, I
Jamard, C
Trepo, C
Zoulim, F
Citation: B. Seigneres et al., Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo, J HEPATOL, 34(1), 2001, pp. 114-122
Authors:
Le Guerhier, F
Pichoud, C
Jamard, C
Guerret, S
Chevallier, M
Peyrol, S
Hantz, O
King, I
Trepo, C
Cheng, YC
Zoulim, F
Citation: F. Le Guerhier et al., Antiviral activity of beta-L-2 ',3 '-dideoxy-2 ',3 '-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus, ANTIM AG CH, 45(4), 2001, pp. 1065-1077
Authors:
Bain, C
Fatmi, A
Zoulim, F
Zarski, JP
Trepo, C
Inchauspe, G
Citation: C. Bain et al., Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection, GASTROENTY, 120(2), 2001, pp. 512-524
Authors:
Hantz, O
Kraus, JL
Zoulim, F
Citation: O. Hantz et al., Design and evaluation of hepatitis B virus inhibitors, CUR PHARM D, 6(5), 2000, pp. 503-523
Authors:
Zoulim, F
Citation: F. Zoulim, Long-term treatment with lamivudine for chronic hepatitis B, GASTRO CL B, 24(12), 2000, pp. 1153-1154
Authors:
Merle, P
Zoulim, F
Vitvitski, L
Trepo, C
Citation: P. Merle et al., The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis, GASTRO CL B, 24(12), 2000, pp. 1166-1176
Authors:
Ahmed, SNS
Tavan, D
Pichoud, C
Berby, F
Stuyver, L
Johnson, M
Merle, P
Abidi, H
Trepo, C
Zoulim, F
Citation: Sns. Ahmed et al., Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B, HEPATOLOGY, 32(5), 2000, pp. 1078-1088
Authors:
Zoulim, F
Trepo, C
Citation: F. Zoulim et C. Trepo, Is lamivudine effective on precore/core promoter mutants of hepatitis B virus?, HEPATOLOGY, 32(5), 2000, pp. 1172-1174
Authors:
Grandjacques, C
Pradat, P
Stuyver, L
Chevallier, M
Chevallier, P
Pichoud, C
Maisonnas, M
Trepo, C
Zoulim, F
Citation: C. Grandjacques et al., Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity, J HEPATOL, 33(3), 2000, pp. 430-439
Authors:
Pichoud, C
Berby, F
Stuyver, L
Petit, MA
Trepo, C
Zoulim, F
Citation: C. Pichoud et al., Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B, J HEPATOL, 32(2), 2000, pp. 307-316
Authors:
Stuyver, L
Van Geyt, C
De Gendt, S
Van Reybroeck, G
Zoulim, F
Leroux-Roels, G
Rossau, R
Citation: L. Stuyver et al., Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy, J CLIN MICR, 38(2), 2000, pp. 702-707
Authors:
Le Guerhier, F
Pichoud, C
Guerret, S
Chevallier, M
Jamard, C
Hantz, O
Li, XY
Chen, SH
King, I
Trepo, C
Cheng, YC
Zoulim, F
Citation: F. Le Guerhier et al., Characterization of the antiviral effect of 2 ',3 '-dideoxy-2 ', 3 '-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model, ANTIM AG CH, 44(1), 2000, pp. 111-122
Authors:
Seigneres, B
Pichoud, C
Ahmed, SS
Hantz, O
Trepo, C
Zoulim, F
Citation: B. Seigneres et al., Evolution of hepatitis B virus polymerase gene sequence during famciclovirtherapy for chronic hepatitis B, J INFEC DIS, 181(4), 2000, pp. 1221-1233
Authors:
Stuyver, L
De Gendt, S
Van Geyt, C
Zoulim, F
Fried, M
Schinazi, RF
Rossau, R
Citation: L. Stuyver et al., A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness, J GEN VIROL, 81, 2000, pp. 67-74
Authors:
Trepo, C
Zoulim, F
Pradat, P
Citation: C. Trepo et al., Viral hepatitis, CURR OPIN I, 12(5), 1999, pp. 481-490
Authors:
Romand, F
Michallet, M
Pichoud, C
Trepo, C
Zoulim, F
Citation: F. Romand et al., Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously immunized against HBV, GASTRO CL B, 23(6-7), 1999, pp. 770-774
Authors:
Zoulim, F
Trepo, C
Citation: F. Zoulim et C. Trepo, New antiviral agents for the therapy of chronic hepatitis B virus infection, INTERVIROLO, 42(2-3), 1999, pp. 125-144